U.S. medical device companies are adopting digital-first and patient-centric operating models to accelerate innovation while meeting rising compliance and cybersecurity requirements, according to a new research report published by Information Services Group (ISG), a global AI-centered technology research and advisory firm.
The 2025 ISG Provider Lens Medical Device Digital Services report for the U.S. finds enterprises are modernizing their product development and post-market digital enablement processes with connected technologies, data-driven quality assurance and sustainability initiatives. As manufacturers face increasing regulatory scrutiny and cost pressures, they are using advanced digital tools to enhance safety, efficiency and patient outcomes while complying with evolving standards.
“U.S. medical device makers are transforming how they design, validate and monitor products,” said Jenn Stein, ISG partner and life sciences industry lead. “By embedding digital compliance and patient-centric design into their operations, they are enhancing agility and trust.”
Digital engineering is helping enterprises reduce time to market and introduce new features without compromising quality. U.S. manufacturers are integrating AI, digital twins and advanced simulation into design and testing to speed product development, the report says. These tools perform real-time analysis of performance data, predictive diagnostics and virtual validation of prototypes. Digital twins are increasingly used to model not just devices but human systems, which helps to make more personalized care possible.
U.S. companies are adopting digital quality management systems and regulatory intelligence platforms to strengthen compliance and reduce administrative burdens, ISG says. AI is helping to make this possible by streamlining documentation, automating risk-based validation and supporting continuous audit readiness. These systems are becoming essential as firms adapt to new frameworks such as the U.S. Food and Drug Administration’s Quality Management System Regulation (QMSR). By embedding compliance in the design of devices, organizations improve traceability and prevent costly post-market revisions.
A growing focus on patients’ needs is reshaping product strategy, the report says. Manufacturers are investing in intuitive interfaces and accessibility features to enhance device usability, which can improve patients’ adherence to care plans. Advances in post-market surveillance and analytics help companies monitor safety, obtain real-world evidence and formulate product improvements. This data-driven approach lets companies respond proactively to patient and regulatory requirements.
“Enterprises that combine compliance, technology and human-centered design are setting new standards for medical innovation,” said Rohan Sinha, senior manager and principal analyst, ISG Provider Lens Research, and lead author of the report. “Service partners play a key role in enabling these companies to safely and ethically invent the future of medical devices.”
The report also explores other medical device trends in the U.S., including the use of eco-friendly materials for sustainability and secure cloud architectures for data protection.
The 2025 ISG Provider Lens Medical Device Digital Services report for the U.S. is available to subscribers or for one-time purchase at: tinyurl.com/2vcht6db
